Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours Β· Estimated delivery Aug 25 - Aug 30
Combined formulation for synergistic protocol design
Current Regulatory Status in the UK Retatrutide is not approved by the MHRA or EMA and is unavailable as a licensed medicine in the UK
What Is AOD 9604
In addition to 0.25% retinol and glycolic acid, it also features 8% LTN Complex, a proprietary blend of tranexamic acid, niacinamide and lotus sprout extract that addresses skin discoloration
Prescription Requirements for Different B12 Formulations Prescription needs for B12 formulations vary by type and patient condition
US$ 20.74
US$ 29.96
US$ 27.12
US$ 25.97
US$ 25.96
US$ 27.92
US$ 21.84
US$ 29.13
US$ 20.48
